miRagen Therapeutics raises $41M in Series C fundraising round

miRagen Therapeutics raises $41M in Series C fundraising round

BOULDER -- miRagen Therapeutics , a biopharmaceutical company developing innovative microRNA-based therapeutics, announced a Series C preferred stock financing with gross proceeds of $41 million,... Read More

Wednesday November 11, 2015 0 comments Tags: Boulder, miRagen Therapeutics, William Marshall

miRagen Therapeutics and Santaris Pharma expand global alliance for microRNA drug discovery

miRagen Therapeutics and Santaris Pharma expand global alliance for microRNA drug discovery

BOULDER - miRagen Therapeutics and Denmark-based Santaris Pharma A/S announced they are expanding an existing partnership to discover and produce drugs to treat more diseases caused by... Read More

By: Steve Thursday January 10, 2013 0 comments Tags: Boulder, Henrik Oerum, microRNA, miRagen Therapeutics, Santaris Pharma, William Marshall

IN Sponsors

Content Garden ad

Browse

InnovatioNews ends 9-year run covering Colorado innovation
A New Sunrise. Stakeholders all await, shapes a path to success too few even see. How often you get & answer questions is one indicator of your readiness
A New Sunrise. Stakeholders all await, shapes a path to success too few even see. How often you get & answer questions is one indicator of your readiness
InnovatioNews on Spring hiatus until May 13
InnovatioNews on Spring hiatus until May 13
The Coming Drone Delivery Revolution – What Comes Next?
The Coming Drone Delivery Revolution – What Comes Next?
Primavera Essentials introduces Neuro-Eze
Primavera Essentials introduces Neuro-Eze

Entrepreneurial by Nature


Colorado Entreprenerial by Nature
Copyright InnovatioNews LLC 2015. All Rights Reserved.